Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophie Ingoure
Observed names:
Ingoure, Sophie,
S. Ingoure
Institution:
Innate Pharma (France)
Observed institutions:
Centre National de la Recherche Scientifique,
Institut de Biologie du Développement Marseille,
Chimie et Biologie des Membranes et des Nanoobjects,
Innate Pharma (France),
Institut Européen de Chimie et Biologie,
Université Bordeaux-I
show all 6
OpenAlex ID:
A5012000875
In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model
2005
·
Hélène Sicard
, Sophie Ingoure
, et al.
·
The Journal of Immunology
·
210
PDF
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
2009
·
Julie Gertner-Dardenne
, Cecile Bonnafous
, et al.
·
Blood
·
168
PDF
Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models
2015
·
F. Lhospice
, D. Brégeon
, et al.
·
Molecular Pharmaceutics
·
120
Synthesis and Biological Activity of Phosphonate Analogues and Geometric Isomers of the Highly Potent Phosphoantigen (E)-1-Hydroxy-2-methylbut-2-enyl 4-Diphosphate
2008
·
Angélique Boëdec
, Hélène Sicard
, et al.
·
Journal of Medicinal Chemistry
·
77
A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates
2007
·
Delphine Cendron
, Sophie Ingoure
, et al.
·
European Journal of Immunology
·
42
PDF
The PPARα pathway in Vγ9Vδ2 T cell anergy
2014
·
Mary Poupot
, Frédéric Boissard
, et al.
·
Cellular & Molecular Biology Letters
·
12
PDF
IPH1101, the First Specific γδ T Cell Agonist, Shows Potent Immuno-Biological Efficacy in Low Grade Follicular Lymphoma Patients When Combined with Rituximab: Results From a Phase II Study.
2009
·
Claire Lucas
, Sophie Ingoure
, et al.
·
Blood
·
4
A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of Vã9Vä2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.
2008
·
Guy Laurent
, Jean François Rossi
, et al.
·
Blood
·
4
9200 Phase II study of IPH1101 (with low dose of IL-2) in combination with rituximab re-treatment in patients with follicular lymphoma
2009
·
O. Casasnovas
, C. Thieblemont
, et al.
·
European Journal of Cancer Supplements
·
1
Cognitive Study of Reactivity to IPH1101 of Peripheral γδ T Lymphocytes from Chronic Myeloid Leukemia, Multiple Myeloma and Follicular Lymphoma Patients.
2008
·
Helene Sicard
, Jean-Francois Rossi
, et al.
·
Blood
·
1
Molecular mechanism of the Vγ9Vδ2 T lymphocytes anergy. (P4385)
2013
·
Mary Poupot
, Severine Fruchon
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
12
Citation count:
639
H-index:
6
I10-index:
6
Year
Topic
Type